Latest News

  • CARAT contributing to advance automatic therapeutic cell production

    Horizon - The EU Research & Innovation Magazine has published an article on the advances of cell production factories in bringing life-saving cell therapies to an ever larger number of patients. The CARAT project is featured in this article as the project is contributing to improve Miltenyi’s CliniMACS Prodigy – a machine built for automatic...
  • Reaching out to the scientific community: Successful CARAT meeting and workshop in Freiburg

    On June 25-27, 2018, the CARAT consortium met for their extended 3rd Progress Meeting kindly hosted by Prof. Toni Cathomen and his team from the University Medical Center in Freiburg. 2.5 years into the project, the agenda was packed not only with internal monitoring and planning activities but also with exciting external undertakings in terms of...
  • CARAT at EBMT in Lisbon

    During the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Lisbon, Portugal, CARAT was very active in further promoting CAR T cells for cellular therapy. A central event was the very successful joint EBMT-CARAT session on March 19, 2018 chaired by Christian Chabannon (Aix-Marseille University School of...
  • Cell Therapy – Challenges & Success Stories

    CARAT approach mentioned as solution for challenges in GoingPublic Magazin
  • CAR T-Cell Immunotherapy Named Advance of the Year in Annual ASCO Report

    A new and unique new way to treat cancer – CAR T-cell therapy – is poised to transform the outlook for children and adults with certain otherwise incurable cancers. The American Society of Clinical Oncology (ASCO) named this type of adoptive cell immunotherapy the Advance of the Year in its annual report. Released within the scope of the World...
  • CARAT Training Fellowship

    GMP-compliant CAR T Cell Manufacturing Training Course December 10-14, 2018
  • Medical College of Wisconsin: first successful treatment of CART patient and use of Miltenyi’s CliniMACS Prodigy®

    The Medical College of Wisconsin has published a press release reporting on their first successfully treated CART patient and how they used Miltenyi’s CliniMACS Prodigy®.  Physicians and researchers from the Medical College of Wisconsin (MCW), Froedtert Hospital, Children's Hospital of Wisconsin, and BloodCenter of Wisconsin have...
  • First CARAT training course on “GMP-compliant CAR T cell manufacturing” completed

    Just at the end of the first half of the CARAT project, a first one-week training course on “GMP-compliant CAR T cell manufacturing” took place on December 11-15, 2017at Miltenyi Biotec headquarters in Bergisch Gladbach, Germany. Five outstanding scientists from all over Europe with profound experience in the cell and gene therapy field were...

Upcoming Events